QY

Quismat Yunus

Active Director Director DIN 10077240
DIN 10077240 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Quismat Yunus

Data last updated:

Quismat Yunus is a Director at Insia Healthcare Diagnostics Private Limited (since 2023). Insia Healthcare Diagnostics Private Limited reported revenue of ₹25,841 (FY 2024).

DIN 10077240
Primary Designation Director
First Appointment 17 Mar 2023
Oldest Company Age 3 yrs
Largest company Insia Healthcare Diagnostics Private Limited · ₹25,841 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20232023₹25,841 (FY 2024)Active

Board colleagues of Quismat Yunus

NameDINCompanyDesignation
Md Imran Yunus10077241Insia Healthcare Diagnostics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Insia Healthcare Diagnostics Private Limited
Premium access

Shareholding and investment profile for Quismat Yunus

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quismat Yunus

Quismat Yunus currently holds 1 directorship: Insia Healthcare Diagnostics Private Limited (Director, since 17 Mar 2023, revenue ₹25,841 (FY 2024)).

Quismat Yunus was first appointed on 17 Mar 2023 as Director at Insia Healthcare Diagnostics Private Limited.

The current boards of Quismat Yunus's companies include Md Imran Yunus (Insia Healthcare Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available